Evidence Synthesis
PANACEABIO's 54.66% gross margin accelerated to, up from -1.12%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 18 Sept 2026, 03:10
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
PANACEABIO's 54.66% gross margin accelerated to, up from -1.12%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 54.66 % | -1.12 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -1.12 % | -1.06 | ▼ |
| REVENUE_GROWTH_YOY | 19.7 % | -42.4 | ▲ |
| EPS_ACTUAL | -5.49 INR | — | - |
| EPS_SURPRISE_PERCENT | -4.05 % | — | - |
| PRICE_CHANGE_PERCENT | 1.321 % | — | - |
| DAILY_VOLUME | 72,261 shares | 2,26,826 | ▼ |
| CLOSE_PRICE | 372 INR | 367.15 | ▲ |